I Vergote Selected Research

I Vergote Research Topics

Disease

64	Ovarian Neoplasms (Ovarian Cancer) 12/2023 - 01/2000
61	Neoplasms (Cancer) 01/2023 - 03/2000
27	Breast Neoplasms (Breast Cancer) 04/2021 - 09/2000
14	Carcinoma (Carcinomatosis) 01/2020 - 01/2000
13	Ovarian Epithelial Carcinoma 01/2021 - 05/2000
12	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 09/2000
10	Neoplasm Metastasis (Metastasis) 10/2022 - 07/2000
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 08/2005
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 06/2001
4	Disease Progression 11/2019 - 05/2003
4	Thrombocytopenia (Thrombopenia) 01/2018 - 03/2000
4	Rupture 01/2009 - 03/2000
3	Pain (Aches) 01/2018 - 10/2003
3	Fatigue 01/2018 - 10/2003
3	Residual Neoplasm 02/2013 - 01/2006
3	Adenocarcinoma 09/2006 - 01/2001
2	Hemorrhage 01/2021 - 05/2007
2	Neutropenia 01/2020 - 03/2000
2	Microsatellite Instability 01/2020 - 05/2001
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2018 - 10/2003
2	Nausea 09/2014 - 10/2003
2	Pleural Effusion (Pleural Effusions) 03/2010 - 03/2008
2	Vulvar Neoplasms (Vulvar Cancer) 09/2009 - 06/2001
2	Sarcoma (Soft Tissue Sarcoma) 04/2008 - 07/2007
2	Ascites 09/2005 - 07/2000
2	Carcinosarcoma 09/2005 - 03/2003
2	Leiomyoma (Uterine Fibroids) 01/2005 - 10/2001
2	Polyps 01/2005 - 09/2000
2	Vomiting 11/2003 - 10/2003
2	Uterine Hemorrhage (Uterine Bleeding) 11/2000 - 09/2000
1	Genomic Instability 01/2023
1	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 02/2021
1	Pelvic Infection 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2020

Drug/Important Bio-Agent (IBA)

39	PlatinumIBA 12/2023 - 01/2000
17	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 03/2000
15	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 03/2000
12	Cisplatin (Platino)FDA LinkGeneric 09/2013 - 01/2000
11	Tamoxifen FDA LinkGeneric 01/2014 - 09/2000
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2009
8	Hormones (Hormone)IBA 01/2021 - 09/2000
7	Fulvestrant (Faslodex)FDA Link 02/2006 - 08/2002
6	liposomal doxorubicin (Doxil)FDA Link 01/2023 - 09/2009
6	Anastrozole (Arimidex)FDA LinkGeneric 03/2004 - 09/2000
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 01/2018
5	1-dodecylpyridoxal (PLD)IBA 01/2023 - 09/2009
5	Topotecan (Hycamtin)FDA LinkGeneric 01/2021 - 12/2000
4	olaparibIBA 12/2023 - 01/2022
4	Aromatase InhibitorsIBA 08/2011 - 12/2003
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2023 - 11/2020
3	Bevacizumab (Avastin)FDA Link 01/2023 - 08/2017
3	TrabectedinIBA 01/2023 - 01/2011
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 03/2011
3	Estrogen ReceptorsIBA 01/2014 - 05/2003
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2003 - 05/2000
3	DNA (Deoxyribonucleic Acid)IBA 10/2003 - 03/2000
3	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2003 - 01/2001
2	AnthracyclinesIBA 04/2021 - 10/2012
2	human ERBB2 proteinIBA 01/2021 - 07/2008
2	Trastuzumab (Herceptin)FDA Link 01/2021 - 01/2009
2	niraparibIBA 11/2020 - 01/2018
2	Phenobarbital (Luminal)FDA Link 02/2018 - 10/2012
2	trebananibIBA 01/2016 - 09/2014
2	MicroRNAs (MicroRNA)IBA 09/2013 - 05/2010
2	Epirubicin (Ellence)FDA LinkGeneric 10/2012 - 11/2003
2	Progesterone Receptors (Progesterone Receptor)IBA 10/2012 - 01/2009
2	thiaclopridIBA 08/2012 - 02/2012
2	Estrogens (Estrogen)FDA Link 01/2009 - 11/2005
2	SteroidsIBA 07/2008 - 11/2007
2	ParaffinIBA 10/2006 - 06/2000
2	Gemcitabine FDA Link 01/2006 - 05/2005
2	Progesterone FDA LinkGeneric 11/2005 - 09/2000
2	Ifosfamide FDA LinkGeneric 03/2003 - 01/2000
2	Indicators and Reagents (Reagents)IBA 01/2001 - 01/2001
1	nintedanibIBA 01/2023
1	glycoprotein CX 1IBA 01/2023
1	Taxoids (Taxanes)IBA 04/2021
1	Capecitabine (Xeloda)FDA Link 04/2021
1	mirvetuximab soravtansineIBA 01/2021
1	vasectrin II (VS II)IBA 12/2020

Therapy/Procedure

43	Therapeutics 12/2023 - 06/2000
31	Drug Therapy (Chemotherapy) 12/2023 - 06/2001
8	Radiotherapy 01/2023 - 05/2006
8	Lymph Node Excision (Lymph Node Dissection) 10/2022 - 05/2006
7	Neoadjuvant Therapy 10/2012 - 01/2006
6	Hysterectomy 01/2021 - 02/2004
5	Drug Tapering 01/2022 - 03/2003
5	Adjuvant Chemotherapy 03/2010 - 03/2000
4	TP protocol 04/2013 - 05/2000
4	Combination Drug Therapy (Combination Chemotherapy) 09/2007 - 01/2001
3	Immunotherapy 01/2019 - 06/2014
3	Cytoreduction Surgical Procedures 10/2013 - 03/2008
2	Palliative Care (Palliative Therapy) 08/2009 - 06/2001
2	Vulvectomy 09/2004 - 06/2001
1	Maintenance Chemotherapy 12/2023
1	Conservative Treatment 01/2023
1	Curettage 02/2021
1	Blood Transfusion (Blood Transfusions) 01/2021
1	Robotic Surgical Procedures 01/2021